Inovio pharmaceuticals ceo
Web2 days ago · Inovio Pharmaceuticals Inc. closed $2.48 short of its 52-week high ($3.42), which the company achieved on April 14th. The stock outperformed some of its competitors Thursday, as Johnson &... WebNov 5, 2024 · Effective immediately, four experienced and talented leaders will all join the executive team and report to INOVIO's President and CEO, Dr. J. Joseph Kim. Dr. Kim said, …
Inovio pharmaceuticals ceo
Did you know?
WebSep 29, 2010 · BLUE BELL, Pa., Sep 29, 2010 (BUSINESS WIRE) -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Joseph Kim, President & CEO, has been named Life Sciences CEO of the Year by the Philadelphia Business Journal … WebMar 15, 2024 · Dr. J. Joseph Kim, INOVIO's President and CEO, said, "Michael is a seasoned legal executive with deep life sciences experience both in the US and abroad. His …
WebMay 10, 2024 · Since joining as Chief Operating Officer in March 2024, Dr. Shea has shown exceptional leadership and technical expertise overseeing INOVIO's manufacturing, … WebExhibit 10.2 . SECOND AMENDMENT TO ASSET PURCHASE AGREEMENT . THIS SECOND AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is made and entered into as of March 24, 2012 (“Effective Date”), between OncoSec Medical Incorporated, a Nevada corporation (the “Purchaser”), and Inovio Pharmaceuticals, Inc. (the “Company”), a …
WebAug 19, 2015 · INOVIO Pharmaceuticals, Inc. Jun 2009 - Present13 years 11 months Member of the Board of Trustees International Vaccine Institute (IVI) Nov 2013 - Feb 20246 years 4 months Chair, Compensation... WebFor its 2024 fiscal year, INOVIO PHARMACEUTICALS, INC., listed the following CEO pay ratio data on its annual proxy statement to the SEC. Board of Directors in INOVIO PHARMACEUTICALS, INC. For its 2024 fiscal year, INOVIO PHARMACEUTICALS, INC., listed the following board members on its annual proxy statement to the SEC.
WebFeb 4, 2024 · Inovio Pharmaceuticals Inc has a market cap of $2.98 billion; its shares were traded at around $14.560000 with and P/S ratio of 856.49. GuruFocus has detected 5 …
WebAug 11, 2024 · Joining us today are Dr. J. Joseph Kim, President and CEO; Dr. Kate Broderick, Senior Vice President of Research and Development and Project Lead for Inovio's infectious disease programs; Dr.... diamond dust lapping compoundWebSep 21, 2024 · Inovio Pharmaceuticals, Inc. ( NASDAQ: INO) Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit Conference Call September 21, 2024 9:55 AM ET Company Participants Joseph Kim -... diamond dust marilynWebMar 12, 2024 · Effective immediately, Inovio's global clinical and R&D functions will report to Dr. Laurent Humeau, Inovio's Chief Scientific Officer and Executive Vice President. As a part of this... diamond dust landscapingWebJan 15, 2024 · Dr. J. Joseph Kim, Inovio's President & CEO said, "We are fortunate to have Jay Shepard join Inovio's Board of Directors. Jay's expertise in health care, corporate … diamond dust meteorologyWeb1 day ago · Shares of Inovio Pharmaceuticals Inc. INO, -9.05% shed 9.05% to $0.85 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index... diamond dust meaningWebINOVIO Pharmaceuticals, Inc. 4 years 2 months Chief Executive Officer May 2024 - Present1 year Plymouth Meeting, Pennsylvania, United States Chief … diamond dust krylon glitter blast spray paintWebApr 3, 2024 · At INOVIO, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. diamond dust glitter spray paint